Cusabio Technology LLC

647 posts

Cusabio Technology LLC banner
Cusabio Technology LLC

Cusabio Technology LLC

@cusabio_mt

Cusabio is a biotechnology enterprise specialized in the R&D, production and sales of Elisa kit, protein and antibodies.

7505 Fannin St. Ste 610-322 Katılım Mayıs 2019
163 Takip Edilen172 Takipçiler
Sabitlenmiş Tweet
Cusabio Technology LLC
Cusabio Technology LLC@cusabio_mt·
𝐌𝐚𝐬𝐭𝐞𝐫𝐢𝐧𝐠 𝐄𝐋𝐈𝐒𝐀 𝐓𝐞𝐜𝐡𝐧𝐢𝐪𝐮𝐞𝐬: 𝐏𝐫𝐢𝐧𝐜𝐢𝐩𝐥𝐞𝐬, 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝 𝐂𝐮𝐫𝐯𝐞 𝐃𝐫𝐚𝐰𝐢𝐧𝐠 & 𝐃𝐚𝐭𝐚 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 #ELISA is a widely used tool in life sciences and clinical research for precise immune response analysis. This webinar will cover ELISA principles, standard curve development, and data analysis, providing insights to improve data accuracy. Learn more: bit.ly/3F4Fn2T
Cusabio Technology LLC tweet mediaCusabio Technology LLC tweet mediaCusabio Technology LLC tweet mediaCusabio Technology LLC tweet media
English
0
0
1
148
Cusabio Technology LLC
Cusabio Technology LLC@cusabio_mt·
#Transthyretin (#TTR) transports thyroid hormones (T4/T3) and vitamin A, ensuring proper metabolic regulation, growth, and visual function. When misfolded, TTR forms amyloid aggregates, the main pathological feature of hereditary transthyretin #amyloidosis (#hATTR), leading to nerve and organ damage. #CUSABIO provides high-quality, application-validated TTR reagents, supported by expert technical service. 👉 Discover our full TTR reagent portfolio: bit.ly/4ixfAis
Cusabio Technology LLC tweet media
English
0
1
1
91
Cusabio Technology LLC
Cusabio Technology LLC@cusabio_mt·
As #diabetes rates rise, #GCGR (Glucagon Receptor) is gaining attention for its role in regulating blood glucose. Drugs targeting GCGR, developed by Novo Nordisk and Eli Lilly, are already on the market. The combination of GCGR with multi-target receptor agonists is emerging as a promising new approach. With more companies entering the space, the GCGR market is set for disruption. Today, let's learn more about GCGR. bit.ly/4kuUmmZ
Cusabio Technology LLC tweet media
English
0
0
0
114
Cusabio Technology LLC
Cusabio Technology LLC@cusabio_mt·
A recent study reveals how Neurotensin (NTS) regulates food intake by controlling lipid metabolism in white adipocytes. Depleting NTSR2 in adipocytes increased food intake, while NTS treatment suppressed it. The mechanism involves ceramide synthetase 2, which increases ceramides C20–C24, raising food intake and lowering GDF15 levels. The study also found a correlation between ceramide levels and food intake across different populations. These findings highlight the role of NTS-NTSR2 signaling and ceramides in appetite regulation. nature.com/articles/s4142…
Cusabio Technology LLC tweet media
English
0
0
0
53
Cusabio Technology LLC
Cusabio Technology LLC@cusabio_mt·
DYRK1A regulates essential processes like the cell cycle, proliferation, differentiation, and apoptosis. By modulating phosphorylation in various signaling pathways, it influences cellular stability and activity. Abnormal expression or mutations of DYRK1A are linked to diseases like Down syndrome, neurodegenerative disorders, and cancer. CUSABIO offers high-quality DYRK1A reagents validated for multiple applications, supported by strict quality control and expert technical assistance. bit.ly/43RdqWx #DYRK1A #CellBiology #NeurodegenerativeDiseases
Cusabio Technology LLC tweet media
English
0
0
0
50
Cusabio Technology LLC
Cusabio Technology LLC@cusabio_mt·
📢 𝐇𝐚𝐩𝐩𝐞𝐧𝐢𝐧𝐠 𝐓𝐨𝐝𝐚𝐲 – 𝐌𝐚𝐬𝐭𝐞𝐫𝐢𝐧𝐠 𝐄𝐋𝐈𝐒𝐀 𝐓𝐞𝐜𝐡𝐧𝐢𝐪𝐮𝐞𝐬: 𝐏𝐫𝐢𝐧𝐜𝐢𝐩𝐥𝐞𝐬, 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝 𝐂𝐮𝐫𝐯𝐞 𝐃𝐫𝐚𝐰𝐢𝐧𝐠 & 𝐃𝐚𝐭𝐚 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 To accommodate our global audience, we’re hosting three sessions—pick the time that works best for you: 🕘 𝐌𝐚𝐫𝐜𝐡 𝟏𝟗 🔹 𝟑:𝟎𝟎 𝐏𝐌 𝐉𝐒𝐓/𝐊𝐒𝐓 🔹 𝟐:𝟎𝟎 𝐏𝐌 𝐂𝐄𝐓 🔹 𝟏𝟏:𝟎𝟎 𝐀𝐌 𝐏𝐃𝐓 / 𝟐:𝟎𝟎 𝐏𝐌 𝐄𝐃𝐓 🎁 𝐁𝐨𝐧𝐮𝐬: 𝐀𝐥𝐥 𝐚𝐭𝐭𝐞𝐧𝐝𝐞𝐞𝐬 𝐡𝐚𝐯𝐞 𝐚 𝐜𝐡𝐚𝐧𝐜𝐞 𝐭𝐨 𝐰𝐢𝐧 𝐚 𝐅𝐑𝐄𝐄 𝟐𝟒𝐓 𝐄𝐋𝐈𝐒𝐀 𝐭𝐫𝐢𝐚𝐥 𝐤𝐢𝐭! 👉 𝐋𝐞𝐚𝐫𝐧 𝐦𝐨𝐫𝐞: bit.ly/3F4Fn2T #ELISA #Webinar #DataAnalysis #StandardCurve #LifeScience
Cusabio Technology LLC tweet media
English
0
0
0
26
Cusabio Technology LLC
Cusabio Technology LLC@cusabio_mt·
NKG2D is an activated receptor expressed on the surface of NK cells and CD8+ T cells, playing a critical role in innate immunity by recognizing virus-infected and tumor cells. This makes it a valuable target in CAR-T and CAR-NK cell therapies. In November 2020, Nkarta Therapeutics marked a milestone with the first patient delivery of NKX101, a universal CAR-NK cell therapy targeting NKG2D for the treatment of relapsed/refractory AML and high-risk MDS. This follows earlier advancements in CAR-T NKG2D therapies, like CYAD-01 in 2018, which reached a major milestone in the treatment of metastatic colorectal cancer and achieved complete remission in patients with r/r AML. The success of NKG2D-based therapies highlights its immense potential in revolutionizing cancer treatment. Read more: bit.ly/3FBTq0b #NKG2D #CART #CARNK #Immunotherapy #CancerResearch #Biotech #ClinicalTrials
Cusabio Technology LLC tweet media
English
0
0
0
93
Cusabio Technology LLC
Cusabio Technology LLC@cusabio_mt·
🚨 Only 3 Days Left! 🚨 Join Us for the ELISA Techniques Webinar. 👉 bit.ly/3F4Fn2T
Cusabio Technology LLC@cusabio_mt

𝐌𝐚𝐬𝐭𝐞𝐫𝐢𝐧𝐠 𝐄𝐋𝐈𝐒𝐀 𝐓𝐞𝐜𝐡𝐧𝐢𝐪𝐮𝐞𝐬: 𝐏𝐫𝐢𝐧𝐜𝐢𝐩𝐥𝐞𝐬, 𝐒𝐭𝐚𝐧𝐝𝐚𝐫𝐝 𝐂𝐮𝐫𝐯𝐞 𝐃𝐫𝐚𝐰𝐢𝐧𝐠 & 𝐃𝐚𝐭𝐚 𝐀𝐧𝐚𝐥𝐲𝐬𝐢𝐬 #ELISA is a widely used tool in life sciences and clinical research for precise immune response analysis. This webinar will cover ELISA principles, standard curve development, and data analysis, providing insights to improve data accuracy. Learn more: bit.ly/3F4Fn2T

English
0
0
0
39
Cusabio Technology LLC
Cusabio Technology LLC@cusabio_mt·
Angiotensin-converting enzyme 2 (#ACE2), first identified in 2000, plays a pivotal role in regulating blood pressure and fluid balance as part of the #RAAS and #KKS systems. This metalloproteinase (805 amino acids) has a crucial extracellular catalytic domain, and its gene is located on the X chromosome. At CUSABIO, we provide high-quality ACE2 reagents backed by rigorous quality control, validated for multiple research applications. bit.ly/3FBILmk
Cusabio Technology LLC tweet media
English
0
0
1
37
Cusabio Technology LLC
Cusabio Technology LLC@cusabio_mt·
Are you looking to refine your ELISA skills and improve your data analysis? Join us for a free, in-depth webinar! bit.ly/3F4Fn2T What You’ll Learn: • Introduction to the ELISA principle • Development and data processing of standard curve for quantitative ELISA • Data analysis for qualitative ELISA • Common problems in standard curve development and their solutions
Cusabio Technology LLC tweet media
English
0
0
0
21
Cusabio Technology LLC
Cusabio Technology LLC@cusabio_mt·
Globally, 400 million people are obese and 19.3 million are diagnosed with cancer yearly. Many suffer from cancer-related cachexia, yet no standard treatment exists. GFRAL, identified as the GDF-15 receptor in 2017, plays a key role in appetite and metabolism. Emerging studies highlight its potential as a therapeutic target for cachexia and obesity. What’s the role of the GFRAL/GDF-15 axis—and its clinical value? Let’s explore: bit.ly/3Fnf601
Cusabio Technology LLC tweet media
English
0
0
0
60
Cusabio Technology LLC
Cusabio Technology LLC@cusabio_mt·
Animals regulate food intake through internal setpoints, but how these setpoints are encoded remains unclear. A new study in Drosophila reveals that protein intake setpoints vary by sex and mating status and are stored within protein hunger neurons as resting membrane potential. Two opposing GPCR signaling pathways adjust this setpoint: FMRFa-FMRFaR-PKC lowers protein intake, while MS-MSR2-PKA increases it. By mapping protein appetite to a physiological parameter, this research provides new insights into how neural circuits regulate feeding behavior. 👉 Read more here: cell.com/cell/fulltext/… #Neuroscience #GPCR #Metabolism #Drosophila #ProteinIntake #Biotech
Cusabio Technology LLC tweet media
English
0
0
0
73